Our objective is to address the fundamental question concerning the extent to which genetic background modulates human susceptibility to head and neck squamous cell carcinoma (SCCHN). Interindividual and interethnic differences in tobacco carcinogen metabolism are considered to be major contributors to variations observed in disease susceptibility. In addition to variability in activation and detoxification pathways of mutagenic agents, variability in the capacity to repair smoking induced DNA damage is likely to represent another major family of susceptibility biomarkers. The nucleotide excision repair (NER) system is important in the repair of chemical carcinogen induced genotoxic damage. The XPD protein is a key member of this pathway and mutations in the XPD gene, including the common A35931C (Lys751 Gln) variant allele result in reduced repair capacity. Cyclin D1 (CCND1) is an essential cell cycle regulatory protein and is involved in the regulation of proliferation and differentiation. The CCND1 G870A polymorphism has been reported to enhance alternate splicing and increase cyclin D1 protein half-life; consequently subjects with the variant allele may have increased susceptibility to increased cell proliferation and the promotion of genetic instability by the bypass of the G1/S checkpoint of the cell cycle control mechanism. We propose to assess the effect of genetic polymorphisms in the XPD and CCND1 genes on susceptibility to HNSCC in order to further refine the HNSCC risk assessment model for individuals with smoking and/or alcohol consumption. We plan to extend our initial observations of an association between elevated risk of upper aerodigestive tract cancer among individuals who carried both the CCND1870A variant allele and XPD Gln allele (10.4, 95%CI 5.3-20.4).
In specific aim 1, we will validate these results in a series of matched SCCHN cases (N=750) and controls (N=1000).
Specific aim 2 will evaluate whether these CCND1 and/or XPD genetic polymorphisms are associated with elevated risk of recurrence or development of a second primary tumor.
In specific aim 3, we propose to determine the correlation between CCND1 and XPD polymorphisms in peripheral blood mononuclear cells (PBMC) and, genetic alterations in SCCHN tissues.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA097190-05
Application #
7658091
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
5
Fiscal Year
2008
Total Cost
$495,855
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Johnston, Paul A; Sen, Malabika; Hua, Yun et al. (2018) High Content Imaging Assays for IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines. Methods Mol Biol 1683:229-244
Palliyaguru, Dushani L; Yuan, Jian-Min; Kensler, Thomas W et al. (2018) Isothiocyanates: Translating the Power of Plants to People. Mol Nutr Food Res 62:e1700965
Gleber-Netto, Frederico O; Zhao, Mei; Trivedi, Sanchit et al. (2018) Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer 124:84-94
Santuray, Rodell T; Johnson, Daniel E; Grandis, Jennifer R (2018) New Therapies in Head and Neck Cancer. Trends Cancer 4:385-396
Liu, Zhuqing; McMichael, Elizabeth L; Shayan, Gulidanna et al. (2018) Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients. Clin Cancer Res 24:4529-4538
Lu, Shanhong; Concha-Benavente, Fernando; Shayan, Gulidanna et al. (2018) STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV+ status in head and neck cancer. Oral Oncol 78:186-193
Nikiforova, Marina N; Mercurio, Stephanie; Wald, Abigail I et al. (2018) Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules. Cancer 124:1682-1690
Zhong, Qian; Liu, Zhi-Hua; Lin, Zhi-Rui et al. (2018) The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma. Clin Cancer Res 24:659-673
Ma, Jing; Salamoun, Joseph; Wipf, Peter et al. (2018) Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential. Oncotarget 9:6042-6054
Hartman, Douglas J; Ahmad, Fahad; Ferris, Robert L et al. (2018) Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma. Oral Oncol 86:278-287

Showing the most recent 10 out of 310 publications